
|Articles|April 1, 2004
Q-switched combination laser provides option for treating hyperpigmentation
Dallas - A new Q-switched combination 532/1,064 Nd:YAG laser provides physicians with an option for treating postsclerotherapy hyperpigmentation, according to a presentation scheduled for the annual meeting of American Society for Laser Medicine and Surgery.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Clascoterone 5% Delivers Strong Phase 3 Hair-Growth Results
2
Alpha-9 Begins First-in-Human Trial of MC1R-Targeted Radiotherapeutic
3
ICYMI: First Patient Dosed in Global Phase 2 Study of Oral TYK2 Inhibitor Soficitinib for PN
4
Dermatology Conferences and Meetings Calendar: December 2025
5


















